Nature Medicine, ISSN 1078-8956, 04/2012, Volume 18, Issue 4, pp. 521 - 528
Tyrosine kinase inhibitors (TKIs) elicit high response rates among individuals with kinase-driven malignancies, including chronic myeloid leukemia (CML) and...
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | APOPTOSIS | GEFITINIB | BIOCHEMISTRY & MOLECULAR BIOLOGY | EYE DISEASES | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | CELL LUNG-CANCER | FACTOR RECEPTOR EGFR | GROWTH | ACTIVATING MUTATIONS | MUTANT EGFR | Enzyme-Linked Immunosorbent Assay - methods | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Follow-Up Studies | Apoptosis - drug effects | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | BH3 Interacting Domain Death Agonist Protein - genetics | Dose-Response Relationship, Drug | Protein Isoforms - metabolism | Transfection | Bcl-2-Like Protein 11 | Statistics, Nonparametric | Aged, 80 and over | Apoptosis Regulatory Proteins - genetics | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lung Neoplasms - genetics | Annexins - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Membrane Proteins - genetics | Gene Frequency | Exons - genetics | Genotype | Proto-Oncogene Proteins - genetics | International Cooperation | Drug Resistance, Neoplasm - genetics | Cell Line, Tumor | Polymorphism, Genetic - genetics | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Cohort Studies | Drug Resistance, Neoplasm - drug effects | Protein Isoforms - genetics | RNA, Small Interfering - metabolism | Sequence Deletion - genetics | Antimitotic agents | Physiological aspects | Protein tyrosine kinase | Dosage and administration | Genetic aspects | Research | Antineoplastic agents | Tumor proteins | Genetic polymorphisms | Inhibitor drugs | Mutation | Kinases | Gene expression | Apoptosis | Polymorphism
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | APOPTOSIS | GEFITINIB | BIOCHEMISTRY & MOLECULAR BIOLOGY | EYE DISEASES | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | CELL LUNG-CANCER | FACTOR RECEPTOR EGFR | GROWTH | ACTIVATING MUTATIONS | MUTANT EGFR | Enzyme-Linked Immunosorbent Assay - methods | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Follow-Up Studies | Apoptosis - drug effects | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | BH3 Interacting Domain Death Agonist Protein - genetics | Dose-Response Relationship, Drug | Protein Isoforms - metabolism | Transfection | Bcl-2-Like Protein 11 | Statistics, Nonparametric | Aged, 80 and over | Apoptosis Regulatory Proteins - genetics | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lung Neoplasms - genetics | Annexins - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Membrane Proteins - genetics | Gene Frequency | Exons - genetics | Genotype | Proto-Oncogene Proteins - genetics | International Cooperation | Drug Resistance, Neoplasm - genetics | Cell Line, Tumor | Polymorphism, Genetic - genetics | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Cohort Studies | Drug Resistance, Neoplasm - drug effects | Protein Isoforms - genetics | RNA, Small Interfering - metabolism | Sequence Deletion - genetics | Antimitotic agents | Physiological aspects | Protein tyrosine kinase | Dosage and administration | Genetic aspects | Research | Antineoplastic agents | Tumor proteins | Genetic polymorphisms | Inhibitor drugs | Mutation | Kinases | Gene expression | Apoptosis | Polymorphism
Journal Article
Journal of Dental Research, ISSN 0022-0345, 4/2015, Volume 94, Issue 4, pp. 569 - 576
Mandibular prognathism (MP) is a recognizable phenotype associated with dentoskeletal class III malocclusion. MP is a complex genetic trait, although familial...
candidate gene | bone growth | genetic variant | next-generation sequencing | whole-exome sequencing | class III malocclusion | PROTEIN | ANNEXIN-II | FILAMIN | IDENTIFICATION | CHINESE POPULATION | BONE-RESORPTION | CLASS-III MALOCCLUSION | CLONING | DENTISTRY, ORAL SURGERY & MEDICINE | JAPANESE | LINKAGE | Humans | Middle Aged | Male | Malocclusion, Angle Class III - genetics | Mutation, Missense - genetics | Young Adult | Adult | Female | Filamins - genetics | Genetic Linkage - genetics | Child | Glycine - genetics | Genetic Association Studies | Serine - genetics | Genotype | Penetrance | Sequence Analysis, DNA | Homeodomain Proteins - genetics | Meiosis - genetics | Exome - genetics | Annexin A2 - genetics | Bone Morphogenetic Protein 3 - genetics | Pedigree | Adolescent | Aged | Genetic Variation - genetics | GTPase-Activating Proteins - genetics | Genes, Dominant - genetics | Prognathism - genetics
candidate gene | bone growth | genetic variant | next-generation sequencing | whole-exome sequencing | class III malocclusion | PROTEIN | ANNEXIN-II | FILAMIN | IDENTIFICATION | CHINESE POPULATION | BONE-RESORPTION | CLASS-III MALOCCLUSION | CLONING | DENTISTRY, ORAL SURGERY & MEDICINE | JAPANESE | LINKAGE | Humans | Middle Aged | Male | Malocclusion, Angle Class III - genetics | Mutation, Missense - genetics | Young Adult | Adult | Female | Filamins - genetics | Genetic Linkage - genetics | Child | Glycine - genetics | Genetic Association Studies | Serine - genetics | Genotype | Penetrance | Sequence Analysis, DNA | Homeodomain Proteins - genetics | Meiosis - genetics | Exome - genetics | Annexin A2 - genetics | Bone Morphogenetic Protein 3 - genetics | Pedigree | Adolescent | Aged | Genetic Variation - genetics | GTPase-Activating Proteins - genetics | Genes, Dominant - genetics | Prognathism - genetics
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e96239
Glioblastoma is the most common and lethal primary brain tumor. Tumor initiation and recurrence are likely caused by a sub-population of glioblastoma stem...
GLIOMA-CELLS | CANCER-CELLS | GROWTH-FACTOR RECEPTOR | NERVOUS-SYSTEM | IN-VITRO | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | AKT PATHWAY | SPHEROID CULTURES | PRECURSOR CELLS | BRAIN-TUMORS | Neoplastic Stem Cells - cytology | Caspase 9 - genetics | Caspase 9 - metabolism | Humans | Caspase 3 - metabolism | Gene Expression Regulation, Neoplastic | Glycoproteins - metabolism | Peptides - genetics | 3' Untranslated Regions - genetics | Cell Survival - genetics | MicroRNAs - metabolism | Antigens, CD - genetics | Antigens, CD - metabolism | Flow Cytometry | Peptides - metabolism | Bcl-2-Like Protein 11 | Glioblastoma - genetics | Neoplastic Stem Cells - metabolism | Caspase 3 - genetics | Apoptosis Regulatory Proteins - genetics | Glioblastoma - metabolism | Membrane Proteins - metabolism | Cell Survival - physiology | Glycoproteins - genetics | Proto-Oncogene Proteins - metabolism | Membrane Proteins - genetics | Cells, Cultured | Proto-Oncogene Proteins - genetics | AC133 Antigen | Apoptosis Regulatory Proteins - metabolism | Cell Line, Tumor | MicroRNAs - genetics | DNA microarrays | MicroRNA | Analysis | Luciferase | Stem cells | Glioblastoma multiforme | Apoptosis | Brain | Flow cytometry | Brain tumors | Brain cancer | Glioblastoma | Fluorescence | Oncology | Biochemistry | Neurosurgery | Caspase-3 | Cancer therapies | Genetics | Cell survival | MiRNA | Caspase | siRNA | Ribonucleic acid--RNA | Survival | Neurology | Brain research | Mutagenesis | 3' Untranslated regions | Cell number | MicroRNAs | Cell lines | Caspase-9 | Neural stem cells | Annexin V | BIM protein | Cancer | Tumors | RNA | Ribonucleic acid
GLIOMA-CELLS | CANCER-CELLS | GROWTH-FACTOR RECEPTOR | NERVOUS-SYSTEM | IN-VITRO | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | AKT PATHWAY | SPHEROID CULTURES | PRECURSOR CELLS | BRAIN-TUMORS | Neoplastic Stem Cells - cytology | Caspase 9 - genetics | Caspase 9 - metabolism | Humans | Caspase 3 - metabolism | Gene Expression Regulation, Neoplastic | Glycoproteins - metabolism | Peptides - genetics | 3' Untranslated Regions - genetics | Cell Survival - genetics | MicroRNAs - metabolism | Antigens, CD - genetics | Antigens, CD - metabolism | Flow Cytometry | Peptides - metabolism | Bcl-2-Like Protein 11 | Glioblastoma - genetics | Neoplastic Stem Cells - metabolism | Caspase 3 - genetics | Apoptosis Regulatory Proteins - genetics | Glioblastoma - metabolism | Membrane Proteins - metabolism | Cell Survival - physiology | Glycoproteins - genetics | Proto-Oncogene Proteins - metabolism | Membrane Proteins - genetics | Cells, Cultured | Proto-Oncogene Proteins - genetics | AC133 Antigen | Apoptosis Regulatory Proteins - metabolism | Cell Line, Tumor | MicroRNAs - genetics | DNA microarrays | MicroRNA | Analysis | Luciferase | Stem cells | Glioblastoma multiforme | Apoptosis | Brain | Flow cytometry | Brain tumors | Brain cancer | Glioblastoma | Fluorescence | Oncology | Biochemistry | Neurosurgery | Caspase-3 | Cancer therapies | Genetics | Cell survival | MiRNA | Caspase | siRNA | Ribonucleic acid--RNA | Survival | Neurology | Brain research | Mutagenesis | 3' Untranslated regions | Cell number | MicroRNAs | Cell lines | Caspase-9 | Neural stem cells | Annexin V | BIM protein | Cancer | Tumors | RNA | Ribonucleic acid
Journal Article
JAMA, ISSN 0098-7484, 07/2009, Volume 302, Issue 3, pp. 261 - 275
CONTEXT: Gliomas, particularly glioblastomas, are among the deadliest of human tumors. Gliomas emerge through the accumulation of recurrent chromosomal...
BREAST-CANCER | EXPRESSION PATTERNS | SURVIVAL | MOLECULAR CLASSIFICATION | CELLS | MEDICINE, GENERAL & INTERNAL | GLIOBLASTOMA | PROSTATE-CANCER | GROWTH | MALIGNANT GLIOMAS | GENOME | Metalloendopeptidases - genetics | RNA-Binding Proteins - genetics | Prognosis | Genes, Neoplasm | Humans | Middle Aged | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | Male | Risk | Cytochromes c - genetics | Genes, myc | Mitochondrial Proteins | Glioma - genetics | Glioma - pathology | Apoptosis Regulatory Proteins - genetics | Female | Brain Neoplasms - mortality | ATPases Associated with Diverse Cellular Activities | Genome-Wide Association Study | Glioma - mortality | Signal Transduction | Proportional Hazards Models | Brain Neoplasms - genetics | Gene Dosage | Annexin A7 - genetics | Hydroxyprostaglandin Dehydrogenases - genetics | Nuclear Proteins | Dosage Compensation, Genetic | Aldo-Keto Reductase Family 1 Member C3 | Epistasis, Genetic | Chromosome Aberrations | Survival Analysis | Models, Genetic | Mutation | 3-Hydroxysteroid Dehydrogenases - genetics | Gliomas | Genetic aspects | Diagnosis | Research | Identification and classification | Oncogenes | Cancer | Neurology | Genetics | Brain cancer | Tumors
BREAST-CANCER | EXPRESSION PATTERNS | SURVIVAL | MOLECULAR CLASSIFICATION | CELLS | MEDICINE, GENERAL & INTERNAL | GLIOBLASTOMA | PROSTATE-CANCER | GROWTH | MALIGNANT GLIOMAS | GENOME | Metalloendopeptidases - genetics | RNA-Binding Proteins - genetics | Prognosis | Genes, Neoplasm | Humans | Middle Aged | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | Male | Risk | Cytochromes c - genetics | Genes, myc | Mitochondrial Proteins | Glioma - genetics | Glioma - pathology | Apoptosis Regulatory Proteins - genetics | Female | Brain Neoplasms - mortality | ATPases Associated with Diverse Cellular Activities | Genome-Wide Association Study | Glioma - mortality | Signal Transduction | Proportional Hazards Models | Brain Neoplasms - genetics | Gene Dosage | Annexin A7 - genetics | Hydroxyprostaglandin Dehydrogenases - genetics | Nuclear Proteins | Dosage Compensation, Genetic | Aldo-Keto Reductase Family 1 Member C3 | Epistasis, Genetic | Chromosome Aberrations | Survival Analysis | Models, Genetic | Mutation | 3-Hydroxysteroid Dehydrogenases - genetics | Gliomas | Genetic aspects | Diagnosis | Research | Identification and classification | Oncogenes | Cancer | Neurology | Genetics | Brain cancer | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e49047
Inflammatory conditions may promote tumor progression and aggressiveness. In previous reports, we found a group of breast cancer tumors characterized by...
MATRIX METALLOPROTEINASES | CELLS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | HUMAN PAPILLOMA-VIRUS | GROWTH-FACTOR | INHIBITORS | TUMOR-GROWTH | CANCER | EXPRESSION | PROMOTES ANGIOGENESIS | Inflammation - pathology | Interleukin-1 Receptor-Associated Kinases - metabolism | Leukocytes, Mononuclear - metabolism | Interleukin-1 Receptor-Associated Kinases - genetics | Follow-Up Studies | Humans | NF-kappa B - metabolism | Interleukins - metabolism | Breast Neoplasms - metabolism | Interleukins - genetics | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Inflammation - metabolism | Neoplasm Metastasis | Chemokine CCL3 - genetics | Claudin-3 - genetics | Interferon-beta - genetics | Chemokine CCL3 - metabolism | Claudin-3 - metabolism | Female | Carcinoma - pathology | Matrix Metalloproteinase 1 - genetics | Myeloid Differentiation Factor 88 - genetics | Matrix Metalloproteinase 11 - metabolism | Up-Regulation - genetics | Disease Progression | Leukocytes, Mononuclear - pathology | Tissue Inhibitor of Metalloproteinase-1 - genetics | ADAM Proteins - metabolism | Annexin A2 - genetics | Breast Neoplasms - genetics | Interferon-beta - metabolism | NF-kappa B - genetics | Breast Neoplasms - pathology | Matrix Metalloproteinase 11 - genetics | Inflammation - genetics | Carcinoma - genetics | Carcinoma - metabolism | ADAM Proteins - genetics | Matrix Metalloproteinase 1 - metabolism | Annexin A2 - metabolism | Myeloid Differentiation Factor 88 - metabolism | Breast cancer | Inflammation | Prognosis | B cells | Annexins | Analysis | Gene regulation | Metastasis | Matrix metalloproteinase | Tissue inhibitor of metalloproteinase 1 | Metastases | Interleukin 6 | Proteins | Ethics | Angiogenesis | Breast carcinoma | Interleukin 5 | Interleukin 1 | Metalloproteinase | Growth factors | Interstitial collagenase | IRAK protein | ADAMTS-1 protein | Cytokines | Gene expression | Interleukin 17 | Womens health | Medical prognosis | MyD88 protein | Breast | Chemokines | Tumors
MATRIX METALLOPROTEINASES | CELLS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | HUMAN PAPILLOMA-VIRUS | GROWTH-FACTOR | INHIBITORS | TUMOR-GROWTH | CANCER | EXPRESSION | PROMOTES ANGIOGENESIS | Inflammation - pathology | Interleukin-1 Receptor-Associated Kinases - metabolism | Leukocytes, Mononuclear - metabolism | Interleukin-1 Receptor-Associated Kinases - genetics | Follow-Up Studies | Humans | NF-kappa B - metabolism | Interleukins - metabolism | Breast Neoplasms - metabolism | Interleukins - genetics | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Inflammation - metabolism | Neoplasm Metastasis | Chemokine CCL3 - genetics | Claudin-3 - genetics | Interferon-beta - genetics | Chemokine CCL3 - metabolism | Claudin-3 - metabolism | Female | Carcinoma - pathology | Matrix Metalloproteinase 1 - genetics | Myeloid Differentiation Factor 88 - genetics | Matrix Metalloproteinase 11 - metabolism | Up-Regulation - genetics | Disease Progression | Leukocytes, Mononuclear - pathology | Tissue Inhibitor of Metalloproteinase-1 - genetics | ADAM Proteins - metabolism | Annexin A2 - genetics | Breast Neoplasms - genetics | Interferon-beta - metabolism | NF-kappa B - genetics | Breast Neoplasms - pathology | Matrix Metalloproteinase 11 - genetics | Inflammation - genetics | Carcinoma - genetics | Carcinoma - metabolism | ADAM Proteins - genetics | Matrix Metalloproteinase 1 - metabolism | Annexin A2 - metabolism | Myeloid Differentiation Factor 88 - metabolism | Breast cancer | Inflammation | Prognosis | B cells | Annexins | Analysis | Gene regulation | Metastasis | Matrix metalloproteinase | Tissue inhibitor of metalloproteinase 1 | Metastases | Interleukin 6 | Proteins | Ethics | Angiogenesis | Breast carcinoma | Interleukin 5 | Interleukin 1 | Metalloproteinase | Growth factors | Interstitial collagenase | IRAK protein | ADAMTS-1 protein | Cytokines | Gene expression | Interleukin 17 | Womens health | Medical prognosis | MyD88 protein | Breast | Chemokines | Tumors
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 07/2014, Volume 124, Issue 7, pp. 2861 - 2876
Tissue-specific alternative splicing is critical for the emergence of tissue identity during development, yet the role of this process in malignant...
PROGENITOR CELLS | MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN-INTERACTION NETWORKS | STEM-LIKE CELLS | INTEGRATED GENOMIC ANALYSIS | TUMOR-SUPPRESSOR GENE | EXPRESSION ARRAYS | TRACT-BINDING-PROTEIN | FACTOR RECEPTOR GENE | ENDOTHELIAL GROWTH-FACTOR | PRE-MESSENGER-RNA | Receptor, Epidermal Growth Factor - genetics | Alternative Splicing | Exons | Humans | Brain Neoplasms - pathology | MicroRNAs - metabolism | RNA, Messenger - metabolism | Polypyrimidine Tract-Binding Protein - antagonists & inhibitors | RNA, Neoplasm - metabolism | Brain Neoplasms - metabolism | Gene Knockdown Techniques | Receptor, Epidermal Growth Factor - metabolism | Glioblastoma - genetics | Neoplastic Stem Cells - metabolism | Cell Transformation, Neoplastic - genetics | Neoplastic Stem Cells - pathology | Glioblastoma - metabolism | Tumor Cells, Cultured | Cell Lineage - genetics | RNA, Messenger - genetics | Brain Neoplasms - genetics | Heterogeneous-Nuclear Ribonucleoproteins - metabolism | Heterogeneous-Nuclear Ribonucleoproteins - antagonists & inhibitors | Polypyrimidine Tract-Binding Protein - metabolism | Signal Transduction - genetics | Annexin A7 - genetics | Disease Progression | Heterogeneous-Nuclear Ribonucleoproteins - genetics | Glioblastoma - pathology | RNA, Neoplasm - genetics | Neovascularization, Pathologic - genetics | MicroRNAs - genetics | Polypyrimidine Tract-Binding Protein - genetics | Exon (Molecular genetics) | Neoplastic processes | Tumor suppressor genes | Development and progression | Genetic aspects | Properties | Glioblastoma multiforme | Proteins | Senescence | Genes | Rodents | Brain cancer | Medical prognosis | Colleges & universities | Regulation | Tumorigenesis | Mutation | Tumors | Cancer
PROGENITOR CELLS | MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN-INTERACTION NETWORKS | STEM-LIKE CELLS | INTEGRATED GENOMIC ANALYSIS | TUMOR-SUPPRESSOR GENE | EXPRESSION ARRAYS | TRACT-BINDING-PROTEIN | FACTOR RECEPTOR GENE | ENDOTHELIAL GROWTH-FACTOR | PRE-MESSENGER-RNA | Receptor, Epidermal Growth Factor - genetics | Alternative Splicing | Exons | Humans | Brain Neoplasms - pathology | MicroRNAs - metabolism | RNA, Messenger - metabolism | Polypyrimidine Tract-Binding Protein - antagonists & inhibitors | RNA, Neoplasm - metabolism | Brain Neoplasms - metabolism | Gene Knockdown Techniques | Receptor, Epidermal Growth Factor - metabolism | Glioblastoma - genetics | Neoplastic Stem Cells - metabolism | Cell Transformation, Neoplastic - genetics | Neoplastic Stem Cells - pathology | Glioblastoma - metabolism | Tumor Cells, Cultured | Cell Lineage - genetics | RNA, Messenger - genetics | Brain Neoplasms - genetics | Heterogeneous-Nuclear Ribonucleoproteins - metabolism | Heterogeneous-Nuclear Ribonucleoproteins - antagonists & inhibitors | Polypyrimidine Tract-Binding Protein - metabolism | Signal Transduction - genetics | Annexin A7 - genetics | Disease Progression | Heterogeneous-Nuclear Ribonucleoproteins - genetics | Glioblastoma - pathology | RNA, Neoplasm - genetics | Neovascularization, Pathologic - genetics | MicroRNAs - genetics | Polypyrimidine Tract-Binding Protein - genetics | Exon (Molecular genetics) | Neoplastic processes | Tumor suppressor genes | Development and progression | Genetic aspects | Properties | Glioblastoma multiforme | Proteins | Senescence | Genes | Rodents | Brain cancer | Medical prognosis | Colleges & universities | Regulation | Tumorigenesis | Mutation | Tumors | Cancer
Journal Article
7.
Full Text
Genetic variations in the p11/tPA/BDNF pathway are associated with post stroke depression
Journal of Affective Disorders, ISSN 0165-0327, 01/2018, Volume 226, pp. 313 - 325
The effects of BDNF on post stroke depression (PSD) may be influenced by genetic variations in intracellular signal transduction pathways, such as the...
Post stroke depression | Gene | BDNF | Pathway | PSYCHIATRY | NEUROTROPHIC FACTOR | SUSCEPTIBILITY | RISK | RELIABILITY | POSTSTROKE DEPRESSION | MAJOR DEPRESSION | CLINICAL NEUROLOGY | P11 S100A10 | ANNEXIN II TETRAMER | SCALE | Depressive Disorder - genetics | Haplotypes | Brain-Derived Neurotrophic Factor - genetics | Genetic Predisposition to Disease | Gene Frequency | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Genotype | Male | Receptor, trkB - genetics | Depressive Disorder - etiology | Tissue Plasminogen Activator - genetics | Stroke - genetics | Membrane Glycoproteins - genetics | S100 Proteins - genetics | Annexin A2 - genetics | Epistasis, Genetic | Aged, 80 and over | Adult | Female | Aged | Polymorphism, Single Nucleotide | Genetic research | Cellular signal transduction | Genetic aspects | Genetic polymorphisms | Stroke (Disease) | Depression, Mental
Post stroke depression | Gene | BDNF | Pathway | PSYCHIATRY | NEUROTROPHIC FACTOR | SUSCEPTIBILITY | RISK | RELIABILITY | POSTSTROKE DEPRESSION | MAJOR DEPRESSION | CLINICAL NEUROLOGY | P11 S100A10 | ANNEXIN II TETRAMER | SCALE | Depressive Disorder - genetics | Haplotypes | Brain-Derived Neurotrophic Factor - genetics | Genetic Predisposition to Disease | Gene Frequency | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Genotype | Male | Receptor, trkB - genetics | Depressive Disorder - etiology | Tissue Plasminogen Activator - genetics | Stroke - genetics | Membrane Glycoproteins - genetics | S100 Proteins - genetics | Annexin A2 - genetics | Epistasis, Genetic | Aged, 80 and over | Adult | Female | Aged | Polymorphism, Single Nucleotide | Genetic research | Cellular signal transduction | Genetic aspects | Genetic polymorphisms | Stroke (Disease) | Depression, Mental
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2008, Volume 283, Issue 28, pp. 19192 - 19200
The annexin A2 (A2) heterotetramer, consisting of two copies of A2 and two copies of S100A10/p11, promotes fibrinolytic activity on the surface of vascular...
COMPLEX | EPITHELIAL-CELLS | CHANNEL | PHOSPHORYLATION | FUNCTIONAL EXPRESSION | P11 PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECEPTOR | POSTTRANSLATIONAL MECHANISM | PLASMINOGEN | UBIQUITIN-PROTEASOME PATHWAY | Protein Binding - genetics | Oncogene Protein pp60(v-src) - metabolism | Tissue Plasminogen Activator - metabolism | Autoantibodies - blood | Humans | Fibrin - genetics | Ubiquitin - metabolism | Tissue Plasminogen Activator - genetics | S100 Proteins - genetics | Fibrinolysin - genetics | Hemorrhage - etiology | Antiphospholipid Syndrome - genetics | Thrombosis - blood | Antiphospholipid Syndrome - blood | Fibrinolysin - metabolism | Hemorrhage - genetics | Endothelial Cells - metabolism | Oncogene Protein pp60(v-src) - genetics | S100 Proteins - metabolism | Hemorrhage - blood | Ubiquitin - genetics | Leukemia, Promyelocytic, Acute - blood | Protein Transport - genetics | Mice, Knockout | Proteasome Endopeptidase Complex - genetics | Animals | Annexin A2 - genetics | Thrombosis - etiology | Fibrinolysis - genetics | Cell Line, Tumor | Leukemia, Promyelocytic, Acute - complications | Mice | Leukemia, Promyelocytic, Acute - genetics | Proteasome Endopeptidase Complex - metabolism | Fibrin - metabolism | Annexin A2 - metabolism | Ubiquitination - genetics
COMPLEX | EPITHELIAL-CELLS | CHANNEL | PHOSPHORYLATION | FUNCTIONAL EXPRESSION | P11 PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECEPTOR | POSTTRANSLATIONAL MECHANISM | PLASMINOGEN | UBIQUITIN-PROTEASOME PATHWAY | Protein Binding - genetics | Oncogene Protein pp60(v-src) - metabolism | Tissue Plasminogen Activator - metabolism | Autoantibodies - blood | Humans | Fibrin - genetics | Ubiquitin - metabolism | Tissue Plasminogen Activator - genetics | S100 Proteins - genetics | Fibrinolysin - genetics | Hemorrhage - etiology | Antiphospholipid Syndrome - genetics | Thrombosis - blood | Antiphospholipid Syndrome - blood | Fibrinolysin - metabolism | Hemorrhage - genetics | Endothelial Cells - metabolism | Oncogene Protein pp60(v-src) - genetics | S100 Proteins - metabolism | Hemorrhage - blood | Ubiquitin - genetics | Leukemia, Promyelocytic, Acute - blood | Protein Transport - genetics | Mice, Knockout | Proteasome Endopeptidase Complex - genetics | Animals | Annexin A2 - genetics | Thrombosis - etiology | Fibrinolysis - genetics | Cell Line, Tumor | Leukemia, Promyelocytic, Acute - complications | Mice | Leukemia, Promyelocytic, Acute - genetics | Proteasome Endopeptidase Complex - metabolism | Fibrin - metabolism | Annexin A2 - metabolism | Ubiquitination - genetics
Journal Article
Infection and Immunity, ISSN 0019-9567, 06/2016, Volume 84, Issue 6, pp. 1796 - 1805
Tick saliva contains a number of effector molecules that inhibit host immunity and facilitate pathogen transmission. How tick proteins regulate immune...
SYSTEM | INFECTIOUS DISEASES | NAIP/NLRC4 INFLAMMASOMES | RECOGNITION | BORNE PATHOGENS | DOCKING | SERVER | HUMAN GRANULOCYTIC ANAPLASMOSIS | BACTERIAL LIGANDS | NEEDLE PROTEIN | ANAPLASMA-PHAGOCYTOPHILUM INFECTION | IMMUNOLOGY | Interleukin-18 - immunology | Caspases - immunology | Humans | Ixodes - chemistry | Arachnid Vectors - genetics | Interleukin-1beta - genetics | Ixodes - genetics | Calcium-Binding Proteins - immunology | Protein Isoforms - chemistry | Macrophages - microbiology | Calcium-Binding Proteins - chemistry | Amino Acid Sequence | Apoptosis Regulatory Proteins - immunology | Signal Transduction | Apoptosis Regulatory Proteins - chemistry | Models, Molecular | Recombinant Proteins - chemistry | Arachnid Vectors - immunology | Cystatins - immunology | Annexin A2 - genetics | Immune Evasion | Cystatins - genetics | Escherichia coli - genetics | Cystatins - chemistry | Mice | Interleukin-18 - genetics | Ixodes - immunology | Calcium-Binding Proteins - genetics | Ehrlichiosis - pathology | Caspase 1 - immunology | Anaplasma phagocytophilum - genetics | Annexin A2 - chemistry | Escherichia coli - metabolism | Apoptosis Regulatory Proteins - genetics | Annexin A2 - immunology | Macrophages - immunology | Arachnid Vectors - chemistry | Ehrlichiosis - microbiology | Caspases - genetics | Gene Expression Regulation | Ehrlichiosis - immunology | Interleukin-1beta - immunology | Recombinant Proteins - genetics | Inflammasomes - genetics | Anaplasma phagocytophilum - immunology | Animals | Recombinant Proteins - immunology | Caspase 1 - genetics | Inflammasomes - immunology | Protein Binding | Protein Isoforms - immunology | Protein Isoforms - genetics
SYSTEM | INFECTIOUS DISEASES | NAIP/NLRC4 INFLAMMASOMES | RECOGNITION | BORNE PATHOGENS | DOCKING | SERVER | HUMAN GRANULOCYTIC ANAPLASMOSIS | BACTERIAL LIGANDS | NEEDLE PROTEIN | ANAPLASMA-PHAGOCYTOPHILUM INFECTION | IMMUNOLOGY | Interleukin-18 - immunology | Caspases - immunology | Humans | Ixodes - chemistry | Arachnid Vectors - genetics | Interleukin-1beta - genetics | Ixodes - genetics | Calcium-Binding Proteins - immunology | Protein Isoforms - chemistry | Macrophages - microbiology | Calcium-Binding Proteins - chemistry | Amino Acid Sequence | Apoptosis Regulatory Proteins - immunology | Signal Transduction | Apoptosis Regulatory Proteins - chemistry | Models, Molecular | Recombinant Proteins - chemistry | Arachnid Vectors - immunology | Cystatins - immunology | Annexin A2 - genetics | Immune Evasion | Cystatins - genetics | Escherichia coli - genetics | Cystatins - chemistry | Mice | Interleukin-18 - genetics | Ixodes - immunology | Calcium-Binding Proteins - genetics | Ehrlichiosis - pathology | Caspase 1 - immunology | Anaplasma phagocytophilum - genetics | Annexin A2 - chemistry | Escherichia coli - metabolism | Apoptosis Regulatory Proteins - genetics | Annexin A2 - immunology | Macrophages - immunology | Arachnid Vectors - chemistry | Ehrlichiosis - microbiology | Caspases - genetics | Gene Expression Regulation | Ehrlichiosis - immunology | Interleukin-1beta - immunology | Recombinant Proteins - genetics | Inflammasomes - genetics | Anaplasma phagocytophilum - immunology | Animals | Recombinant Proteins - immunology | Caspase 1 - genetics | Inflammasomes - immunology | Protein Binding | Protein Isoforms - immunology | Protein Isoforms - genetics
Journal Article
International Journal for Parasitology, ISSN 0020-7519, 2005, Volume 35, Issue 6, pp. 617 - 626
Through a genome survey and phylogenetic analysis, we have identified and sequenced 14 new coding regions for alpha-giardins in . These proteins are related to...
Parasite | Cytoskeleton | Giardia | Flagella | Annexin | EARLY-DIVERGING EUKARYOTE | PHYLOGENY | PROTEIN | cytoskeleton | INVITRO | EXCYSTATION | CYST WALL | IDENTIFICATION | GENOME | flagella | parasite | annexin | SEQUENCE | BAYESIAN-INFERENCE | PARASITOLOGY | RNA, Protozoan - genetics | Genes, Protozoan - genetics | Genome, Protozoan | Cytoskeletal Proteins - genetics | Gene Expression Regulation - genetics | RNA, Messenger - genetics | Cytoskeleton - genetics | Molecular Sequence Data | Phylogeny | Epitopes - genetics | Protozoan Proteins - genetics | Genetic Vectors - genetics | Animals | Base Sequence | Reverse Transcriptase Polymerase Chain Reaction - methods | Cloning, Molecular - methods | Giardia lamblia - genetics | Proteins | Messenger RNA | Water quality | Genetic research | Marine biology | Annexins | Marine laboratories | Antigenic determinants | RNA; Protozoan/genetics | Mikrobiologi, immunologi, infektionssjukdomar | Medical and Health Sciences | Reverse Transcriptase Polymerase Chain Reaction/methods | Medicin och hälsovetenskap | Mikrobiologi inom det medicinska området | MEDICINE | Cytoskeleton/genetics | Protozoan Proteins/genetics | Cloning; Molecular/methods | Epitopes/genetics | RNA; Messenger/genetics | Gene Expression Regulation/genetics | Basic Medicine | Cytoskeletal Proteins/genetics | Genome; Protozoan | Microbiology in the medical area | Microbiology, immunology, infectious diseases | MEDICIN | Medicinska och farmaceutiska grundvetenskaper | Genetic Vectors/genetics | Giardia lamblia/genetics | Genes; Protozoan/genetics
Parasite | Cytoskeleton | Giardia | Flagella | Annexin | EARLY-DIVERGING EUKARYOTE | PHYLOGENY | PROTEIN | cytoskeleton | INVITRO | EXCYSTATION | CYST WALL | IDENTIFICATION | GENOME | flagella | parasite | annexin | SEQUENCE | BAYESIAN-INFERENCE | PARASITOLOGY | RNA, Protozoan - genetics | Genes, Protozoan - genetics | Genome, Protozoan | Cytoskeletal Proteins - genetics | Gene Expression Regulation - genetics | RNA, Messenger - genetics | Cytoskeleton - genetics | Molecular Sequence Data | Phylogeny | Epitopes - genetics | Protozoan Proteins - genetics | Genetic Vectors - genetics | Animals | Base Sequence | Reverse Transcriptase Polymerase Chain Reaction - methods | Cloning, Molecular - methods | Giardia lamblia - genetics | Proteins | Messenger RNA | Water quality | Genetic research | Marine biology | Annexins | Marine laboratories | Antigenic determinants | RNA; Protozoan/genetics | Mikrobiologi, immunologi, infektionssjukdomar | Medical and Health Sciences | Reverse Transcriptase Polymerase Chain Reaction/methods | Medicin och hälsovetenskap | Mikrobiologi inom det medicinska området | MEDICINE | Cytoskeleton/genetics | Protozoan Proteins/genetics | Cloning; Molecular/methods | Epitopes/genetics | RNA; Messenger/genetics | Gene Expression Regulation/genetics | Basic Medicine | Cytoskeletal Proteins/genetics | Genome; Protozoan | Microbiology in the medical area | Microbiology, immunology, infectious diseases | MEDICIN | Medicinska och farmaceutiska grundvetenskaper | Genetic Vectors/genetics | Giardia lamblia/genetics | Genes; Protozoan/genetics
Journal Article
Oncogene, ISSN 0950-9232, 09/2015, Volume 34, Issue 37, pp. 4867 - 4878
Recent advances in cancer biology have emerged important roles for microRNAs (miRNAs) in regulating tumor responses. However, their function in mediating...
SUPPRESSOR | DUCTAL ADENOCARCINOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR LYMPHANGIOGENESIS | HUMAN-ENDOTHELIAL-CELLS | CANCER | PROMOTES ANGIOGENESIS | CELL BIOLOGY | ONCOLOGY | GROWTH | GENETICS & HEREDITY | NF-KAPPA-B | TRANSCRIPTION FACTOR | EXPRESSION | Human Umbilical Vein Endothelial Cells | ras Proteins - genetics | Cell Proliferation - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Neoplasm Invasiveness | Humans | Pancreatic Neoplasms - pathology | Cells, Cultured | Gene Expression Regulation, Neoplastic | Pancreatic Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Mice, SCID | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - genetics | Animals | Annexin A2 - genetics | HEK293 Cells | Adenocarcinoma - genetics | Mice | MicroRNAs - genetics | MicroRNAs - physiology | Lymphangiogenesis - genetics | Molecular targeted therapy | MicroRNA | Pancreatic cancer | Innovations | Development and progression | Genetic aspects | Properties | Gene expression | Health aspects | Cancer therapies | MicroRNAs | Genes | Cells | Original | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
SUPPRESSOR | DUCTAL ADENOCARCINOMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR LYMPHANGIOGENESIS | HUMAN-ENDOTHELIAL-CELLS | CANCER | PROMOTES ANGIOGENESIS | CELL BIOLOGY | ONCOLOGY | GROWTH | GENETICS & HEREDITY | NF-KAPPA-B | TRANSCRIPTION FACTOR | EXPRESSION | Human Umbilical Vein Endothelial Cells | ras Proteins - genetics | Cell Proliferation - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Neoplasm Invasiveness | Humans | Pancreatic Neoplasms - pathology | Cells, Cultured | Gene Expression Regulation, Neoplastic | Pancreatic Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Mice, SCID | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - genetics | Animals | Annexin A2 - genetics | HEK293 Cells | Adenocarcinoma - genetics | Mice | MicroRNAs - genetics | MicroRNAs - physiology | Lymphangiogenesis - genetics | Molecular targeted therapy | MicroRNA | Pancreatic cancer | Innovations | Development and progression | Genetic aspects | Properties | Gene expression | Health aspects | Cancer therapies | MicroRNAs | Genes | Cells | Original | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article